NCT01438060 - Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type | Biotech Hunter

Enrollment

232

Participants

Timeline

Start Date

August 31, 2000

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions

Dementia, Alzheimer Type

Interventions

DRUG

Aripiprazole (BMS-337039)

"Acute Phase: Oral, Tablets (1 and 5 mg), Week 1-2: 2 mg, Week 3-4: 2 - 5 mg, Week 5-6: 2 - 10 mg, Weeks 7-10: 2 - 15 mg, Once daily, 10 weeks~Extension Phase: Oral, Tablets (1 and 5 mg), Week 11: 2 mg, Weeks 12-13: 2 - 5 mg, Weeks 14-15: 2 - 10 mg, Weeks 16-140: 2 - 15 mg, Once daily, 130 weeks"

DRUG

Placebo

Acute Phase: Oral, Tablets, 0 mg, Once daily, 10 Weeks